CXC Chemokine Modulation of Angiogenesis: The Importance of Balance between Angiogenic and Angiostatic Members of the Family

Journal of Investigative Medicine

Volumn 46, Issue 4, 1998, Pages 113-120

  Moore, Bethany B ^a   Keane, Michael P ^a   Addison, Christina L ^a   Arenberg, Douglas A ^a   Strieter, Robert M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE;

ANGIOGENESIS; ANIMAL; HUMAN; LUNG FIBROSIS; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VASCULARIZATION;

ANIMALS; CHEMOKINES, CXC; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; PULMONARY FIBROSIS;

EID: 0032038939     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (84)

1. Folkman J, Cotran R. Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 1976;16:207-48.
2. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235:442-47.
3. Folkman J, Brem H. Angiogenesis and inflammation. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: basic principles and clinical correlates. 2nd ed. New York: Raven Press Ltd., 1992:821-39.
4. Folkman J. Tumor angiogenesis. In: Holland JF, Frei E III, Bast RD, Kufe DW, Morton DL, Weischelbaum RR, eds. Cancer medicine. 3rd ed. Philadelphia: Lea & Febiger, 1993:153-70.
5. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1(1):27-31.
6. Polverini PJ, Cotran PS, Gimbrone MA, Unanue ER. Activated macrophages induce vascular proliferation. Nature (London) 1977;269(5631):804-6.
7. Polverini PJ. How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases. Eur J Cancer 1996;32A(14):2430-7.
8. Leibovich SJ, Weisman DM. Macrophages, wound repair, and angiogenesis. Prog Clin Biol Res 1988;266:131-45.
9. Auerbach R. Angiogenesis-inducing factors: a review. In: Pick E, Landy M, eds. Lymphokines. New York: Academic Press, 1981:69-88.
10. Gamble JR, Matthias U, Meyer G. Regulation of in vitro capillary tube formation by anti-integrin antibodies. J Cell Biol 1993;121:921-43.
11. Konerding MA, VanAckern C, Steinberg F, Streffer C. Combined morphological approaches in the study of network formation in tumor angiogenesis. Angiogenesis: key principles. Basel: Birkhauser Verlag, 1992:40-58.
12. Paweletz N, Knierim M. Tumor-related angiogenesis. Crit Rev Oncol Hematol 1989;9:197-242.
13. Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994;79(7):1157-64.
14. Luster AD, Greenberg SM, Leder P. The IP-10 chemokine binds to a specific cell surface heparan sulfate shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 1995;182:219-32.
15. Re F, Zanetti A, Sironi M, Polentarutti N, Lanfrancone L, Dejana E, Colotta F. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol 1994;127:537-46.
16. Ferrara N. Vascular endothelial growth factor. Eur J Cancer 1996;14:2413-22.
17. Hanahan D, Folkman J. Pattens and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:356-64.
18. Rogelj S, Klagsbrun M, Atzmon R, Kurokawa M, Haimovitz A, Fuks Z, Vlodavsky I. Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells. J Cell Biol 1989;109(2):823-31.
19. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates suppression of metastases by a Lewis lung carcinoma. Cell 1994;79(2):315-28.
20. Walz A, Kunkel SL, Strieter RM. CXC chemokines-an overview. In: Koch AE, Strieter RM, eds. Chemokines in disease. Austin: R.G. Landes, 1996:1-26.
21. Strieter RM, Kunkel SL. Chemokines and the lung. In: Crystal R. West J, Weibel E, P PB, eds. Lung: scientific foundations, 2nd ed. NY: Raven Press, 1997:155-86.
22. Strieter RM, Lukacs NW, Standiford TJ, Kunkel SL. Cytokines and lung inflammation. Thorax 1993;48:765-9.
23. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-9.
24. Baggiolini M, Dewald B, Walz A. Interleukin-8 and related chemotactic cytokines. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: basic principles and clinical correlates. New York: Raven Press, Ltd., 1992:247-63.
25. Matsushima K, Oppenheim JJ. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1989;1:2-13.
26. Miller MD, Krangel MS. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 1992;12:17-46.
27. Taub DD, Oppenheim JJ. Chemokines, inflammation and immune system. Ther Immunol 1994;1:229-46.
28. Farber JM. Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 1997;61(3):246-57.
29. Rollins BJ. Chemokines. Blood 1997;90:909-28.
30. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996;382:829-33.
31. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier J-L, Arenzana-Seisdedos F, Schwartz O, Heard J-M, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, Moser B. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996;382:833-5.
32. Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, Honjo T. Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 1993;261:600-3.
33. Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, Shinohara T, Honjo T. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF-1) gene. Genomics 1995;28:495-500.
34. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, Chan S, Roczniak S, Shanafelt A. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995;270(45):27348-57.
35. Walz A, Baggiolini M. Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases. Exp Med 1990;171:449-54.
36. Taylor S, Folkman J. Protomine is an inhibitor of angiogenesis. Nature 1982;297:307-12.
37. Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI, Carson HF, Sharpe RJ. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 1990;247(4938):77-9.
38. Maione TE, Gray GS, Hunt AJ, Sharpe RJ. Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Res 1991;51(8):2077-83.
39. Hansell P, Maione TE, Borgstrom P. Selective binding of platelet factor 4 to regions of active angiogenesis in vivo. Am J Physiol 1995;269(3 Pt 2):H829-36.
40. Sharpe RJ, Byers HR, Scott CF, Bauer SI, Maione TE. Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. J Natl Cancer Inst 1990;82(10):848-53.
41. Strieter RM, Kunkel SL, Elner VM, Martonyl CL, Koch AE, Polverini PJ, Elner SG. Interleukin-8: A corneal factor that induces neovascularization. Am J Pathol 1992;141:1279-84.
42. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Einer VM, Elner SG, Strieter RM. Interleukin-8 (IL-8) as a macrophage-derived mediator of angiogenesis. Science 1992; 258:1798-801.
43. Strieter RM, Kunkel SL, Arenberg DA, Burdick MD, Polverini PJ. Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem Biophys Res Commun 1995;210(1):51-7.
44. Arenberg DA, Polverini PJ, Kunkel SL, Shanafelt A, Strieter RM. In vitro and in vivo systems to assess the role of CXC chemokines in the regulation of angiogenesis. Meth Enzymol 1997;190-220.
45. Bouck N. Tumor angiogenesis: the role of oncogenes and tumor suppressor genes. Cancer Cells 1990;2:179-85.
46. Bouck N. Angiogenesis: a mechanism by which oncogenes and tumor suppressor genes regulate tumorigenesis. Cancer Treat Res 1992;63:359-71.
47. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58-61.
48. Maiorana A, Gullino PM. Acquisition of angiogenic capacity and neoplastic transformation in the rat mammary gland. Cancer Res 1978;38:4409-14.
49. Herlyn M, Clark WH, Rodeck U, Manciati ML, Jambrosic J, Koprowski H. Biology of tumor progression in human melanocytes. Lab Invest 1987;56:461-74.
50. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995;147(1):9-19.
51. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Eng. J Med 1991;324:1-8.
52. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-9.
53. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularization to metastasis of nonsmall cell lung cancer. Lancet 1992;340:145-46.
54. Folkman J. Clinical applications of research on angiogenesis. N Eng J Med 1995;333(26):1757-63.
55. Eisenstein R, Kuettner KE, Neopolitan C, Sobel LW, Sorgente N. The resistance of certain tissues to invasion III. Cartilage extracts inhibit the growth of fibroblasts and endothelial cells in culture. Am J Pathol 1975;81:337-47.
56. Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte RI, Burdick MD, Wilke CA, Strieter RM. Inhibition of IL-8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 1994;179:1409-15.
57. Arenberg DA, Kunkel SL, Polverini PJ, Glass M, Burdick MD, Strieter RM. Inhibition of interleukin-8 reduces tumorigenesis of human nonsmall cell lung cancer in SCID mice. J Clin Invest 1996;97(12):2792-802.
58. Luan J, Shattuck-Brandt R, Haghnegahdar H, Owen J, Strieter RM, Burdick M, Nirodi C, Beauchamp D, Newsom-Johnson K, Richmond A. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J Leuk Biol 1997;62(5):588-97.
59. Kitadai Y, Haruma K, Sumii K, Yamamoto S, Ue T, Yokozaki H, Yasui W, Ohmoto Y, Kajiyama G, Fidler IJ, Tahara E. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Path 1998;152(1):93-100.
60. Arenberg DA, Kunkel SL, Polverini PJ, Morris SB, Burdick MD, Glass M, Taub DT, Iannetoni MD, Whyte RI, Strieter RM. Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human nonsmall cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med 1996;184(3):981-92.
61. Turner-Warwick M. Precapillary systemic-pulmonary anastomoses. Thorax 1963;18:225-37.
62. Peao MND, Aguas AP. DeSa CM, Grande NR. Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin. Anat Rec 1994;238:57-67.
63. Keane M, Arenberg D, Lynch JP III, Whyte R, Iannetoni M, Burdick M, Wilke C, Morris S, Glass M, DiGiovive B, Kunkel S, Strieter RM. The CXC chemokines, IL-8, and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 1997;159:1437-43.
64. Stout AJ, Gresser I, Thompson WD. Inhibition of wound healing in mice by local interferon alpha/beta injection. Int J Exp Pathol 1993;74(1):79-85.
65. Hyde DM, Henderson TS, Giri SN, Tyler NK, Stovall MY. Effect of murine gamma interferon on the cellular responses to bleomycin in mice. Exp Lung Res. 1988;14:687-95.
66. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B. Chemokine receptor specific for IP10 and MIG: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996;184(3):963-9.
67. Premack BA, Schall TJ. Chemokine receptors: gateways to inflammation and infection. Nature Med 1996;2:1174-8.
68. Schönbeck U, Brandt E, Petersen F, Flad H, Loppnow H. IL-8 specifically binds to endothelial but not to smooth muscle cells. J Immunol 1995;154:2375-83.
69. Lee J, Horuk R, Rice GC, Bennett GL, Camerato T, Wood WI. Characterization of two high affinity human interleukin-8 receptors. J Biol Chem 1992;267:16283-7.
70. Hadley TJ, Lu Z, Wasniowska K, Peiper SC, Hesselgesser J, Horuk R. Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy bloodgroup antigen. J Clin Invest 1994;94:985-91.
71. Neote K, Darbonne W, Ogez J, Horuk R, Schall T. Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 1993;268:985-91.
72. Nanney LB, Mueller SG, Bueno R, Peiper SC, Richmond A. Distributions of melanoma growth stimulatory activity or growth-related gene and the interleukin-8 receptor type B in human wound repair. Am J Pathol 1995;147(5):1248-60.
73. Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, Cesarman E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation [see comments]. Nature 1997;385(6614):347-50.
74. Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS, Asch AS, Cesarman E, Gerhengorn MC, Mesri EA. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 1998;391:86-9.
75. Boshoff C. Coupling herpesvirus to angiogenesis. Nature 1998;391:24-5.
76. Boshoff C, Endo Y, Collins PD, Takeuchi Y, Reeves JD, Schweickart VL, Siani MA, Sasaki T, Williams TJ, Gray PW, Moore PS, Chang Y, Weiss RA. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 1997;278(5336):290-4.
77. Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996;274(5293):1739-44.
78. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposis's sarcoma. Science 1994;266:1865-9.
79. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences are present in AIDS-related body cavity B-cell lymphoma. N Engl J Med 1995;335:1186-91.
80. Boshoff C, Weiss RA. Kaposis sarcoma associated herpesvirus. Curr Opin Infect Dis 1997;10:26-31.
81. Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS. Nucleotide sequence of the Kaposi's sarcoma-associated herpesvirus (HHV8). Proc. Natl Acad Sci USA 1997;93:14862-7.
82. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, Ganem D. Lytic growth of Kaposi's sarcoma associated herpesvirus (HHV-8) in culture. Nat Med 1996;2(3):342-6.
83. Mesri EA, Cesarman E, L. Arvanitakes, Fafii S, Moore MA, Posnett DN, Knowles DM, Asch AS. Human herpesvirus-8/Kaposi's sarcoma-acssociated herpesvirus is a new transmissible virus that infects B cells. J Exp Med 1996;183:2385-90.
84. Yasumoto K, Okamoto S, Mukaida N, Murakami S, Mai M, Matsushima K. Tumor necrosis factor α and interferon γ synergistically induce interleukin-8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NFκB-like binding sites on the interleukin 8 gene. J Biol Chem 1992;267:22506-11.